Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.40 |
| ▸ | NAT1 | P18440 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | HTR2B | P41595 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12745130 | 0.95 | MEN1 (0.45) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL30564983 | 0.90 | MAPT (0.55) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL283063 | 0.90 | MAPT (0.55) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL283196 | 0.89 | MEN1 (0.59) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL29506706 | 0.89 | MEN1 (0.59) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL12745195 | 0.89 | KMT2A (0.39) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL12745223 | 0.88 | PDK2 (0.41) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL12745256 | 0.88 | PDK2 (0.41) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL15866664 | 0.88 | MAPT (0.57) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL17816646 | 0.88 | MEN1 (0.57) | MEN1KMT2AMAPTKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8729310-B2 | Halogenated diarylamine compound and synthesis method thereof | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-05-20 | — | — | US | disclosed |
| US-8729310-B2 | Halogenated diarylamine compound and synthesis method thereof | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-05-20 | — | — | US | disclosed |
| US-20110071317-A1 | HALOGENATED DIARYLAMINE COMPOUND AND SYNTHESIS METHOD THEREOF | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-03-24 | — | — | US | disclosed |
| US-20110071317-A1 | HALOGENATED DIARYLAMINE COMPOUND AND SYNTHESIS METHOD THEREOF | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110071317-A1 | HALOGENATED DIARYLAMINE COMPOUND AND SYNTHESIS METHOD THEREOF | DDT, NAT1, CYP1A1 | MEN1 359/4885KMT2A 498/4885MAPT 4179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.